Wegovy Pill vs. Injection: Which Is Right for You?
Wegovy now comes as a daily pill or weekly injection. Learn how they compare in effectiveness, dosing, and convenience.
In the United States, Wegovy (semaglutide) is available as a once-daily tablet and a once-weekly injection. Both contain semaglutide, but their dosing, absorption, administration, and switching instructions differ.1
How They Compare
| Feature | Injection | Pill |
|---|---|---|
| Frequency | Once weekly | Once daily |
| Usual maintenance dose for adult weight reduction | 2.4 mg weekly | 25 mg daily |
| Estimated absolute bioavailability | 89% | About 1% to 2% |
| Food timing | With or without meals | Empty stomach in the morning; wait at least 30 minutes afterward |
| Water | No administration-specific limit in the label | Up to 4 oz (120 mL) with the tablet |
| Needle | Yes | No |
Effectiveness
Both formulations have evidence from randomized trials, but they have not been compared directly in a head-to-head weight-loss trial.
- Tablet: In OASIS 4, the estimated mean body-weight change at week 64 was -13.6% with oral semaglutide 25 mg and -2.4% with placebo in the intention-to-treat analysis.13
- Injection: Separate Wegovy injection trials reported substantial average weight reduction, but differences in study populations and methods mean the percentages should not be treated as a direct comparison.1
The better option depends on approved indication, medical history, other medicines, ability to follow the tablet administration routine, access, and clinician guidance.
Dosing Schedules
Injection: The current US label starts at 0.25 mg once weekly and increases every four weeks. The recommended adult maintenance dose for weight reduction is 2.4 mg weekly, with label-specific alternatives based on indication and tolerability.1
Tablet: The current US label starts at 1.5 mg daily for 30 days, then increases to 4 mg for 30 days, 9 mg for 30 days, and 25 mg daily from day 91 onward.1
Key Differences to Consider
Points to discuss about the injection
- Prefer less frequent dosing
- Need to avoid the tablet's morning fasting and medication-timing requirements
- Don't mind self-injecting
Points to discuss about the tablet
- Have needle anxiety
- Prefer oral medications
- Can consistently take it on an empty stomach in the morning with water only and wait at least 30 minutes before food, drinks, or other oral medicines
- Can review possible oral-medication interactions and timing with a clinician or pharmacist
Side Effects
Both versions share the same common side effects:
- Nausea
- Vomiting
- Diarrhea or constipation
- Decreased appetite
The frequency and severity vary. The label includes important warnings and contraindications in addition to common gastrointestinal effects. Contact your healthcare professional about severe or persistent symptoms.1
Access and availability
Approval, supply, insurance coverage, and out-of-pocket cost can change. Confirm current information with your pharmacy, insurer, and the official product website rather than relying on a fixed price in an article.
Frequently Asked Questions
Can I switch from the injection to the pill? The US label includes specific switching instructions for people taking certain maintenance doses. Do not convert doses yourself. Ask your prescriber which instructions apply to you.1
Why is the pill dose (25 mg) so much higher than the injection (2.4 mg)? The formulations are absorbed differently. The label estimates about 1% to 2% absolute bioavailability for the tablet and 89% for the injection.1
What if I eat too soon after taking the pill? Follow the label: take it on an empty stomach in the morning with up to 4 ounces of water and wait at least 30 minutes before eating, drinking, or taking other oral medications.1
Is one more effective than the other? There is no direct head-to-head weight-loss trial establishing that one formulation is more effective. Your clinician can help interpret the evidence in the context of your health and treatment goals.
Dosio supports both oral and injectable routines. The Wegovy tracker page explains the tracking features, while the dose tracker keeps scheduled and actual doses in one timeline.
Important Legal & Medical Disclaimer
Not Medical Advice This article is provided solely for educational purposes. Always consult your healthcare provider to determine which formulation suits your medical history and lifestyle, and to review side effects, contraindications, and monitoring plans.
Do Not Switch Without Guidance
Never switch between Wegovy formulations (injection to pill or vice versa) without clinician supervision. Doses are not equivalent between formulations.
Follow Official Instructions
Always follow the official prescribing information and Instructions for Use (IFU) provided by Novo Nordisk included with your medication packaging.
Sources
-
FDA. Wegovy prescribing information, revised June 2026. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11
-
FDA. NDA approval letter for Wegovy (semaglutide) tablets, December 2025. ↩
-
Wharton S, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine. 2025;393:1077-1087. ↩
